ORBIMED ADVISORS LLC – Fusion Pharmaceuticals Inc. Transaction History
ORBIMED ADVISORS LLC portfolio value:
$9.70M
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
+20.88%
quarter
Fusion Pharmaceuticals Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | 0.00% | 0 shares | 1.67M | $3.01 | 3.22M | |
Q2 2022 | share | 0.00% | 0 shares | -17.02M | $2.49 | 3.22M | |
Q1 2022 | share | 0.00% | 0 shares | 11.60M | $7.77 | 3.22M | |
Q4 2021 | share | 0.00% | 0 shares | -12.09M | $4.49 | 3.22M | |
Q3 2021 | share | 0.00% | 0 shares | -516K | $7.92 | 3.22M | |
Q2 2021 | share | 0.00% | 0 shares | -8.51M | $8.08 | 3.22M | |
Q1 2021 | share | 0.00% | 0 shares | -3.32M | $10.72 | 3.22M | |
Q4 2020 | share | 0.00% | 0 shares | -871K | $11.75 | 3.22M | |
Q3 2020 | share | 0.00% | 0 shares | -17.57M | $12.02 | 3.22M | |
Q2 2020 | share | Increase | 0.00% | 3.22M shares | 56.33M | $17.47 | 3.22M |